Ace Therapeutics is a preclinical contract research provider that offers comprehensive services to support the development of innovative therapies. The company provides a range of preclinical services, including efficacy testing, pharmacokinetics, toxicology, and biomarker development, to researchers at pharmaceutical companies, universities, and research institutions worldwide. Their expertise spans various disease areas, such as respiratory, ophthalmology, cardiovascular, and neurology, and they offer tailored solutions to facilitate preclinical studies, from basic research to preclinical development. Ace Therapeutics aims to accelerate the research and development process for its clients by providing reliable and efficient preclinical services, utilizing state-of-the-art facilities and a team of experienced researchers.

Ace Therapeutics is a preclinical contract research provider. With a team of experienced researchers and top-tier facilities, Ace Therapeutics offers tailored solutions from basic research services to preclinical study services to accelerate the development of innovative therapies.

Basic research services such as gene editing, vector construction, and omics analysis;

Drug discovery services including target discovery and validation, screening, in vitro and in vivo pharmacology, and detection development;

Preclinical testing services that involve laboratory and animal model studies to assess the activity, safety, and pharmacokinetics of drugs or treatment methods before entering clinical trials